+97.3%
GSK vs QSR
+113.6%
-16.3%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | QSR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.6% | -2.2% | +0.6% | -1.0% |
| 7D | -4.7% | -4.3% | -0.4% | -3.7% |
| 30D | -4.7% | -3.8% | -0.9% | -3.8% |
| 3M | -8.8% | -5.5% | -3.3% | -7.6% |
| 6M | -4.6% | -2.9% | -1.7% | -4.1% |
| YTD | +1.0% | +8.8% | -7.8% | -1.4% |
| 1Y | +6.9% | +10.4% | -3.5% | +3.9% |
| 3Y | +52.5% | +12.7% | +39.9% | +46.0% |
| 5Y | +40.3% | +50.5% | -10.2% | +23.9% |
| All | +97.3% | +113.6% | -16.3% | +60.3% |
Cumulative growth
Daily Returns
Daily percentage return beside QSR.
Daily Out/Under-Performance
Portfolio return minus QSR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × QSR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded QSR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling